Travel-associated acquisition of hepatitis C virus infection in patients receiving haemodialysis

Nephrology Dialysis Transplantation

Volumn 22, Issue 9, 2007, Pages 2640-2644

  Ghafur, Abdul ^a   Raza, Muhammad ^a   Labbett, Wendy ^a   Chawla, Anuradha ^a   Smith, Colette ^a   Ngui, Siew Lin ^b   Davenport, Andrew ^a   Geretti, Anna Maria ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Haemodialysis; HCV antibody; HCV RNA; Hepatitis C virus; Seroconversion; Seroprevalence

Indexed keywords

AMINOTRANSFERASE; HEPATITIS C ANTIBODY; VIRUS RNA;

ADOLESCENT; ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BLOOD ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE SURVEILLANCE; FEMALE; FOLLOW UP; GENOTYPE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INCIDENCE; INDIA; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; SCHOOL CHILD; SCREENING TEST; TRAVEL; UNITED KINGDOM;

DEMOGRAPHY; DNA, VIRAL; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; LONDON; MALE; PHYLOGENY; PREVALENCE; RENAL DIALYSIS; SEQUENCE ANALYSIS, DNA; TRAVEL;

EID: 34548435247     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm202     Document Type: Article

References (16)

1. Jadoul M, Poignet JL, Geddes C, Locatelli F, Medin C, Krajewska, M et al. The changing epidemiology of hepatitis C virus (HCV) infection in haemodialysis: European multicentre study. Nephrol Dial Transplant 2004; 19: 904-909
2. Bergman S, Accortt N, Turner A, Glaze J. Hepatitis C infection is acquired pre-ESRD. Am J Kidney Dis 2005; 45: 684-689
3. Schneeberger PM, Keur I, van Loon AM et al. The prevalence and incidence of hepatitis C virus infections among dialysis patients in the Netherlands: A nationwide prospective study. J Infect Dis 2000; 182: 1291-1299
4. Sypsa V, Psichogiou M, Katsoulidou A et al. Incidence ind patterns of hepatitis C virus seroconversion in a cohort of hemodialysis patients. Am J Kidney Dis 2005; 45: 334-343
5. Izopet J, Sandres-Saune K, Kamar N et al. Incidence of HCV infection in French hemodialysis units: A prospective study. J Med Virol 2005; 77: 70-76
6. Good Practice Guidelines for Renal Dialysis/Transplantation Units: Prevention and Control of Blood-borne Virus Infection; Department of Health (UK): Recommendations of a working group convened by the Public Health Laboratory Service (PHLS) on behalf of the Department of Health
7. Silini E, Fulvia B, Cerino A, Piazza V, Solcia E, Mondelli MU. Virological features of hepatitis C infection in haemodialysis patients. Clin Microbiol 1993; 31: 2913-2917
8. Bukh J, Wantzin P, Krogsgaard K. High prevalence of hepatitis C virus RNA in dialysis patients: Failure of commercially available antibody tests to identify a significant number of patients with HCV infection. J Infect Dis 1993; 168: 1343-1348
9. Sakamoto N, Enomoto N, Marumo, F, Sato C. Prevalence of hepatitis C virus infection among long-term hemodialysis patients: Detection of hepatitis, C virus RNA in plasma. J Med Virol 1993; 39: 11-15
10. Schneeberger M, Keur I, van der Vliet van Hoek K, Boswijk H, van Loon AM. Hepatitis C virus infections in dialysis centers in The Netherlands: a national survey by serological and molecular methods. J Clin Microbiol 1998; 36: 1711-1715
11. Hinrichsen H, Leimenstoll G, Stegen G, Schrader H Folsch UR, Schmidt WE. Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: A multicentre study in 2796 patients. Gut 2002; 51: 429-433
12. Hanuka N, Sikuler E, Tovbin D et al. Hepatitis C Virus infection in renal failure patients in the absence of anti-hepatitis C virus antibodies. J Virol Hepat 200; 9: 141-145
13. Kalantar-Zadeh K, Miller LG, Daar ES. Diagnostic discordance for hepatitis C virus infection in hemodialysis patients. Am J Kidney Dis 2005; 46: 290-300
14. Rigopoulou EI, Stefanidis I, Liaskos C et al. HCV-RNA qualitative assay based on transcription mediated amplification improves the detection of hepatitis C virus infection in patients on hemodialysis: results from five hemodialysis units in central Greece. J Clin Virol 2005; 34: 81-85
15. Sheu JC, Lee SH, Wang JT, Shih LN, Wang TH, Chen DS. Prevalence of anti-HCV and HCV viremia in hemodialysis patients in Taiwan. J Med Virol 1992; 37: 108-112
16. Mellor J, Holmes EC, Jarvis LM, Yap PL, Simmonds P. Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: Implications for virus classification. The International HCV Collaborative Study Group. J Gen Virol 1995; 76: 2493-2507